News and Opinion - IPHA

News and Opinion

March 11, 2024

Highlights from IPHA Conference 7th March 2024

     
March 11, 2024

Minister Donnelly IPHA annual conference 2024

March 7, 2024

New Figures Reveal Challenge of Reducing Patient Wait Time for New Medicines

New data compiled by industry shows lengthy timelines for access to new medicines that improve care standards in Ireland Two years in the reimbursement process is too […]
December 7, 2023

Innovative medicines make a difference to patients’ lives, yet in Ireland we continue to wait

Delayed access to time-critical new medicines, the focus of an Oireachtas briefing session. Interrupting the continuous flow of new medicines due to lack of investment is […]
October 19, 2023

‘Dr Google’ is one of the least likely sources that Irish people would consider in looking for information to treat minor health conditions

Contrary to popular belief, a general internet search and social media are some of the least likely sources that people would consider when it comes to […]
October 11, 2023

Budget 2024: Delays and deterioration in patients’ outcomes result of no new funding for new innovative medicines

Scientific innovation has advanced significantly over the past number of years bringing new hope and therapies to patients around the globe. Unfortunately, as a result of […]
September 14, 2023

New ‘Innovate For Life’ films explore how innovation today can transform all our lives tomorrow

Amgen, MSD and Gilead feature in IPHA’s campaign that demonstrates the promise of science through animation style storytelling. Thursday, 14th September 2023 The Irish Pharmaceutical Healthcare […]
July 3, 2023

An increased proportion of healthcare professionals and 100% of Healthcare Organisations have provided full transparency on www.transferofvalue.ie

Last Friday, June 30th, IPHA published the Transfer of value (ToV) Disclosure data for 2022. The total ToV amount for 2022 was €26,140,927 which is a […]
April 28, 2023

Continued long waits for new medicines in Ireland means Minister Donnelly’s new Working Group must deliver change

In 2022, it took on average 567 days from EMA authorisation to availability to patients of new innovative medicines in Ireland, among the slowest in western […]